Krensavage-Asset-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
14
Total Value
180885
Accession Number
0001609251-25-000004
Form Type
13F-HR
Manager Name
Krensavage-Asset-Management
Data Enrichment
100% identified
14 identified0 unidentified

Holdings

14 positions • $180.9K total value
Manager:
Search and click to pin securities to the top
EXELIXIS, INC.
Shares:878.5K
Value:$32.4M
% of Portfolio:17931.3% ($32.4M/$180.9K)
UNITED THERAPEUTICS Corp
Shares:98.2K
Value:$30.3M
% of Portfolio:16740.5% ($30.3M/$180.9K)
CARDINAL HEALTH INC
Shares:188.7K
Value:$26.0M
% of Portfolio:14375.4% ($26.0M/$180.9K)
SUPERNUS PHARMACEUTICALS, INC.
Shares:432.0K
Value:$14.1M
% of Portfolio:7821.5% ($14.1M/$180.9K)
Jazz Pharmaceuticals plc
Shares:100.7K
Value:$12.5M
% of Portfolio:6911.6% ($12.5M/$180.9K)
ENANTA PHARMACEUTICALS INC
Shares:2.1M
Value:$11.7M
% of Portfolio:6459.4% ($11.7M/$180.9K)
GSK plc
Shares:272.0K
Value:$10.5M
% of Portfolio:5825.2% ($10.5M/$180.9K)
INDIVIOR PLC
Shares:965.4K
Value:$9.2M
% of Portfolio:5086.1% ($9.2M/$180.9K)
Shares:149.1K
Value:$8.3M
% of Portfolio:4571.4% ($8.3M/$180.9K)
BioNTech SE
Shares:87.6K
Value:$8.0M
% of Portfolio:4407.8% ($8.0M/$180.9K)
AVADEL PHARMACEUTICALS PLC
Shares:950.0K
Value:$7.4M
% of Portfolio:4112.6% ($7.4M/$180.9K)
Alkermes plc.
Shares:207.8K
Value:$6.9M
% of Portfolio:3793.6% ($6.9M/$180.9K)
Vanda Pharmaceuticals Inc.
Shares:754.4K
Value:$3.5M
% of Portfolio:1914.5% ($3.5M/$180.9K)
Mural Oncology plc
Shares:70.3K
Value:$89.0K
% of Portfolio:49.2% ($89.0K/$180.9K)